News and Trends 27 Jan 2023
FDA clearance for ‘revolutionary’ approach to J-Pouch issue
ExeGi Pharma LLC, which develops live biotherapeutic drugs and probiotics, says the FDA has cleared its Investigational New Drug (IND) application for its biologic drug candidate, EXE-346. The clearance allows…